Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy
- PMID: 15190345
- DOI: 10.1038/nature02580
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy
Abstract
The molecular complexity of tissues and the inaccessibility of most cells within a tissue limit the discovery of key targets for tissue-specific delivery of therapeutic and imaging agents in vivo. Here, we describe a hypothesis-driven, systems biology approach to identifying a small subset of proteins induced at the tissue-blood interface that are inherently accessible to antibodies injected intravenously. We use subcellular fractionation, subtractive proteomics and bioinformatics to identify endothelial cell surface proteins exhibiting restricted tissue distribution and apparent tissue modulation. Expression profiling and gamma-scintigraphic imaging with antibodies establishes two of these proteins, aminopeptidase-P and annexin A1, as selective in vivo targets for antibodies in lungs and solid tumours, respectively. Radio-immunotherapy to annexin A1 destroys tumours and increases animal survival. This analytical strategy can map tissue- and disease-specific expression of endothelial cell surface proteins to uncover novel accessible targets useful for imaging and therapy.
Comment in
-
Molecular medicine: the writing is on the vessel wall.Nature. 2004 Jun 10;429(6992):618-9. doi: 10.1038/429618a. Nature. 2004. PMID: 15190341 No abstract available.
Similar articles
-
Molecular medicine: the writing is on the vessel wall.Nature. 2004 Jun 10;429(6992):618-9. doi: 10.1038/429618a. Nature. 2004. PMID: 15190341 No abstract available.
-
Proteomic profiling of endothelial cells in human lung cancer.J Proteome Res. 2008 Mar;7(3):1138-50. doi: 10.1021/pr7007237. Epub 2008 Jan 26. J Proteome Res. 2008. PMID: 18220333
-
Screening phage display libraries for organ-specific vascular immunotargeting in vivo.Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):407-12. doi: 10.1073/pnas.0506938103. Epub 2005 Dec 29. Proc Natl Acad Sci U S A. 2006. PMID: 16384919 Free PMC article.
-
Advances in endothelial shear stress proteomics.Expert Rev Proteomics. 2014 Oct;11(5):611-9. doi: 10.1586/14789450.2014.933673. Epub 2014 Jul 12. Expert Rev Proteomics. 2014. PMID: 25017810 Review.
-
Vascular proteomic mapping in vivo.J Thromb Haemost. 2007 Jul;5 Suppl 1:183-7. doi: 10.1111/j.1538-7836.2007.02551.x. J Thromb Haemost. 2007. PMID: 17635725 Review.
Cited by
-
Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy.PLoS One. 2022 Nov 22;17(11):e0276462. doi: 10.1371/journal.pone.0276462. eCollection 2022. PLoS One. 2022. PMID: 36413536 Free PMC article.
-
Lung vascular targeting using antibody to aminopeptidase P: CT-SPECT imaging, biodistribution and pharmacokinetic analysis.J Vasc Res. 2010;47(6):531-43. doi: 10.1159/000313880. Epub 2010 Apr 30. J Vasc Res. 2010. PMID: 20431301 Free PMC article.
-
Proteomics analysis of plasma membrane from liver sinusoidal endothelial cells after partial hepatectomy by an improved two-dimensional electrophoresis.Mol Cell Biochem. 2010 Nov;344(1-2):137-50. doi: 10.1007/s11010-010-0537-z. Epub 2010 Jul 6. Mol Cell Biochem. 2010. PMID: 20607590
-
Novel target for peptide-based imaging and treatment of brain tumors.Mol Cancer Ther. 2014 Apr;13(4):996-1007. doi: 10.1158/1535-7163.MCT-13-0684. Epub 2014 Feb 3. Mol Cancer Ther. 2014. PMID: 24493698 Free PMC article.
-
More effective nanomedicines through particle design.Small. 2011 Jul 18;7(14):1919-31. doi: 10.1002/smll.201100442. Epub 2011 Jun 22. Small. 2011. PMID: 21695781 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical